334 filings
Page 16 of 17
8-K
xb7pycftcksrjk8w
8 Feb 19
INmune Bio to Present at BIO CEO & Investor Conference
11:41am
8-K
qz3zx yixn38
8 Feb 19
Regulation FD Disclosure
12:00am
8-K
qzf8yez0bu5
6 Feb 19
Entry into a Material Definitive Agreement
4:38pm
CERT
fxk7 vrq4ux5o
1 Feb 19
Certification of approval for exchange listing
4:47pm
8-A12B
8h5epnywiacj9vnjy
1 Feb 19
Registration of securities on exchange
11:38am
FWP
dj4e78my5eeoy6
24 Jan 19
Free writing prospectus
1:21pm
8-K
5e7bv0cdyo0z2 50
17 Jan 19
INmune Bio, Inc. Announces Pricing of Initial Public Offering
3:59pm
424B3
tgz4yi2
21 Dec 18
Prospectus supplement
1:46pm
EFFECT
0tis8m kxvgvd2oxvqb
20 Dec 18
Notice of effectiveness
12:15am
CORRESP
10vkj55o
17 Dec 18
Correspondence with SEC
12:00am
CORRESP
v7riubo bjobnnnjb
17 Dec 18
Correspondence with SEC
12:00am
CORRESP
fjzpwvx2s
30 Nov 18
Correspondence with SEC
12:00am
UPLOAD
h9czlzft
6 Nov 18
Letter from SEC
12:00am
FWP
nvr9t8k 0zrz7
1 Nov 18
Free writing prospectus
2:44pm
CORRESP
6i3v9xb4xicv2jpuq85
29 Oct 18
Correspondence with SEC
12:00am
UPLOAD
ob8810x at9m
5 Oct 18
Letter from SEC
12:00am
FWP
dwc18o0nfqfv5bwo9
4 Oct 18
Free writing prospectus
9:11pm
S-1/A
b9nk0m6nd04tsn6smlq
26 Sep 18
IPO registration (amended)
12:00am